Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings.

Journal of hepatology - 1 Sept 2013

Xu Dao-Zhen, Wang Xuan-Yi, Shen Xin-Liang, Gong Guo-Zhong, Ren Hong, Guo Li-Min, Sun Ai-Min, Xu Min, Li Lan-Juan, Guo Xin-Hui, Zhen Zhen, Wang Hui-Fen, Gong Huan-Yu, Xu Cheng, Jiang Nan, Pan Chen, Gong Zuo-Jiong, Zhang Ji-Ming, Shang Jia, Xu Jie, Xie Qing, Wu Tie-Feng, Huang Wen-Xiang, Li Yong-Guo, Xu Jing, Yuan Zheng-Hong, Wang Bin, Zhao Kai, Wen Yu-Mei

Abstract excerpt

BACKGROUND & AIMS: Even though various experimental therapeutic approaches for chronic hepatitis B infection have been reported, few of them have been verified by clinical trials. We have developed an antigen-antibody (HBsAg-HBIG) immunogenic complex therapeutic vaccine candidate with alum as adj...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Antigen-Antibody Complex

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Double-Blind Method

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Hepatitis B Surface Antigens

Share to Immunoglobulins

Share to Viral Vaccines

Source

Identifiers

PMID: 23669281
DOI: 10.1016/j.jhep.2013.05.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23669281-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings.PMID 23669281Read ↗

Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines.Semantic proximity Read ↗

Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection.Semantic proximity Read ↗

Hepatitis B vaccine: prophylactic, therapeutic, and diagnostic dilemma.Semantic proximity Read ↗

Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccineSemantic proximity Read ↗

Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.Semantic proximity Read ↗

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.Semantic proximity Read ↗

Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver.Semantic proximity Read ↗

Hepatitis B vaccine efficacy in patients with chronic liver disease by hepatitis C virus.Semantic proximity Read ↗

Immune Response to GeneVac-B® (rDNA I.P. Hepatitis B Vaccine) in Vaccinated Persons with a Standard Schedule in Bobo-Dioulasso, Burkina FasoSemantic proximity Read ↗

Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.Semantic proximity Read ↗

Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity.Semantic proximity Read ↗

DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.